Biogen, Elan's Tysabri Is Worth Rare, Fatal Risk, Patients Say
Biogen, Elan's Tysabri Is Worth Rare, Fatal Risk, Patients Say
Bloomberg - USA
The drug Tysabri allowed him to take walks with his wife again. ... ``Most of us are pro-Tysabri because we failed all other therapies.''. ...
See all stories on this topic
New Ratings - USA
1024 GMT [Dow Jones] Elan's (ELN) suspended MS drug Tysabri gets an upbeat editorial in The New England Journal of Medicine alongside saftey review details and ...
See all stories on this topic
0 Comments:
Post a Comment
<< Home